OPTI vs. KOD, ORPH, AMPH, ANW, MRK, CYAN, OKYO, PHE, IGAS, and REVB
Should you be buying OptiBiotix Health stock or one of its competitors? The main competitors of OptiBiotix Health include Kodal Minerals (KOD), Open Orphan (ORPH), Aggregated Micro Power (AMPH), Aberdeen New Thai Investment Trust (ANW), Marks Electrical Group (MRK), CyanConnode (CYAN), OKYO Pharma (OKYO), PowerHouse Energy Group (PHE), IGas Energy (IGAS), and Revolution Beauty Group (REVB). These companies are all part of the "pharmaceutical products" industry.
OptiBiotix Health vs.
OptiBiotix Health (LON:OPTI) and Kodal Minerals (LON:KOD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings, community ranking and institutional ownership.
OptiBiotix Health has a beta of 1.71, indicating that its share price is 71% more volatile than the S&P 500. Comparatively, Kodal Minerals has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500.
In the previous week, Kodal Minerals had 5 more articles in the media than OptiBiotix Health. MarketBeat recorded 5 mentions for Kodal Minerals and 0 mentions for OptiBiotix Health. Kodal Minerals' average media sentiment score of 0.12 beat OptiBiotix Health's score of 0.00 indicating that Kodal Minerals is being referred to more favorably in the news media.
Kodal Minerals has a net margin of 0.00% compared to OptiBiotix Health's net margin of -524.43%. Kodal Minerals' return on equity of 0.08% beat OptiBiotix Health's return on equity.
Kodal Minerals has a consensus target price of GBX 1.23, suggesting a potential upside of 320.96%. Given Kodal Minerals' stronger consensus rating and higher possible upside, analysts plainly believe Kodal Minerals is more favorable than OptiBiotix Health.
4.9% of OptiBiotix Health shares are owned by institutional investors. Comparatively, 0.0% of Kodal Minerals shares are owned by institutional investors. 12.0% of OptiBiotix Health shares are owned by insiders. Comparatively, 30.1% of Kodal Minerals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
OptiBiotix Health received 31 more outperform votes than Kodal Minerals when rated by MarketBeat users. However, 62.98% of users gave Kodal Minerals an outperform vote while only 59.18% of users gave OptiBiotix Health an outperform vote.
Kodal Minerals has lower revenue, but higher earnings than OptiBiotix Health. OptiBiotix Health is trading at a lower price-to-earnings ratio than Kodal Minerals, indicating that it is currently the more affordable of the two stocks.
Summary
Kodal Minerals beats OptiBiotix Health on 13 of the 17 factors compared between the two stocks.
Get OptiBiotix Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OptiBiotix Health Competitors List
Related Companies and Tools
This page (LON:OPTI) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy OPTI Stock Free OPTI Stock Alerts